Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Free Report

White Paper_2017_State of China Life Science

State of China Life Science - 2017H1

Over $10B invested in last 18 months! Download free report on life science investment in China.

Deals & Financings

VC fundings, mergers and acquisitions, and other financing events...

Zensun Raises $76 Million for Novel Drug Portfolio
Adlai Nortye In-Licenses Oncolytic's Cancer Drug in $86.6 Million Deal
Shanghai Pharma Plans to Use M&A to Expand Overseas
Shanghai Pharma Acquires Cardinal's China Drug Distribution Business for $1.2 Billion
CorestoneBio Plans China JV with Boston's Respiratory Motion
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China